Supply Chain Council of European Union | Scceu.org
Distribution

Pharmacy Chain Says It Can Rep Class If Lead Is DQ’d

Law360 (June 3, 2020, 7:03 PM EDT) — A Midwest pharmacy chain said Tuesday that it’s ready to fill in as head of a direct purchaser class accusing Actavis and Shire of illegally delaying the sale of a generic version of Shire’s ADHD medication Intuniv if the pharmaceutical companies manage to decertify the class’s current named plaintiff.

Even if wholesaler Rochester Drug Co-Operative’s bankruptcy renders it unable to lead the drug buyers in Massachusetts federal court, Meijer Inc. said it’s “ready to serve” in order to prevent the full decertification of the class sought by the pharma companies. It’s already represented by the same attorneys handling the case that…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related posts

Temporary shortage of fuel needs more practical solutions | Business

scceu

BLW: Strong Corporate Bond CEF, 8.8% Distribution Yield, Low Duration (NYSE:BLW)

scceu

Harbor Docks Charities raise more than $80,000 for Take a Kid Fishing Day

scceu